메스암페타민 (Korean Wikipedia)

Analysis of information sources in references of the Wikipedia article "메스암페타민" in Korean language version.

refsWebsite

Global rank Korean rank

7nih.gov

4^th place

4doi.org

2^nd place

3^rd place

4web.archive.org

1^st place

3historyhit.com

low place

4,636^th place

3naver.com

46^th place

2^nd place

2spo.go.kr

low place

498^th place

2who.int

195^th place

98^th place

1chemspider.com

8,573^rd place

1,502^nd place

1harvard.edu

18^th place

27^th place

1fda.gov

447^th place

433^rd place

1worldcat.org

5^th place

11^th place

1resource.org

8,910^th place

6,149^th place

1kegg.jp

low place

1law.go.kr

3,019^th place

14^th place

1mfds.go.kr

low place

1,240^th place

chemspider.com

〈Properties: Predicted – EP|Suite〉. 《Methmphetamine》. 《Chemspider》.

doi.org

dx.doi.org

Rau T, Ziemniak J, Poulsen D (2015). “The neuroprotective potential of low-dose methamphetamine in preclinical models of stroke and traumatic brain injury”. 《Prog. Neuropsychopharmacol. Biol. Psychiatry》 64: 231–6. doi:10.1016/j.pnpbp.2015.02.013. PMID 25724762. In humans, the oral bioavailability of methamphetamine is approximately 70% but increases to 100% following intravenous (IV) delivery (Ares-Santos et al., 2013).
Sellers EM, Tyndale RF (2000). “Mimicking gene defects to treat drug dependence”. 《Ann. N. Y. Acad. Sci.》 909 (1): 233–246. Bibcode:2000NYASA.909..233S. doi:10.1111/j.1749-6632.2000.tb06685.x. PMID 10911933. Methamphetamine, a central nervous system stimulant drug, is p-hydroxylated by CYP2D6 to less active p-OH-methamphetamine.
Krueger SK, Williams DE (June 2005). “Mammalian flavin-containing monooxygenases: structure/function, genetic polymorphisms and role in drug metabolism”. 《Pharmacol. Ther.》 106 (3): 357–387. doi:10.1016/j.pharmthera.2005.01.001. PMC 1828602. PMID 15922018.
Table 5: N-containing drugs and xenobiotics oxygenated by FMO
Schep LJ, Slaughter RJ, Beasley DM (August 2010). “The clinical toxicology of metamfetamine”. 《Clinical Toxicology》 48 (7): 675–694. doi:10.3109/15563650.2010.516752. ISSN 1556-3650. PMID 20849327.

fda.gov

accessdata.fda.gov

“Adderall XR Prescribing Information” (PDF). 《United States Food and Drug Administration》. Shire US Inc. December 2013. 12–13쪽. 2013년 12월 30일에 확인함.

harvard.edu

adsabs.harvard.edu

Sellers EM, Tyndale RF (2000). “Mimicking gene defects to treat drug dependence”. 《Ann. N. Y. Acad. Sci.》 909 (1): 233–246. Bibcode:2000NYASA.909..233S. doi:10.1111/j.1749-6632.2000.tb06685.x. PMID 10911933. Methamphetamine, a central nervous system stimulant drug, is p-hydroxylated by CYP2D6 to less active p-OH-methamphetamine.

historyhit.com

“보관된 사본”. 2019년 4월 1일에 원본 문서에서 보존된 문서. 2019년 4월 4일에 확인함.
“보관된 사본”. 2019년 4월 1일에 원본 문서에서 보존된 문서. 2019년 4월 4일에 확인함.
“보관된 사본”. 2019년 4월 1일에 원본 문서에서 보존된 문서. 2019년 4월 4일에 확인함.

kegg.jp

“医療用医薬品 : ヒロポン (商品詳細情報)”. 2021년 6월 12일에 확인함.

law.go.kr

“국가법령정보센터”. 2021년 6월 12일에 확인함.

mfds.go.kr

“안내서/지침 목록 | 식품의약품안전처”. 2021년 6월 11일에 확인함.

naver.com

newslibrary.naver.com

국민건강 좀먹는 대용마약 환각제 동아일보, 1968.4.23.
히로뽕 만들어 일본에 밀수출 마약성 각성제 경향신문, 1968.4.18.

n.news.naver.com

日, 北 화물선 '히로뽕 밀수 의혹' 강제수색 동아일보, 2006.5.13.

nih.gov

ncbi.nlm.nih.gov

Rau T, Ziemniak J, Poulsen D (2015). “The neuroprotective potential of low-dose methamphetamine in preclinical models of stroke and traumatic brain injury”. 《Prog. Neuropsychopharmacol. Biol. Psychiatry》 64: 231–6. doi:10.1016/j.pnpbp.2015.02.013. PMID 25724762. In humans, the oral bioavailability of methamphetamine is approximately 70% but increases to 100% following intravenous (IV) delivery (Ares-Santos et al., 2013).
Sellers EM, Tyndale RF (2000). “Mimicking gene defects to treat drug dependence”. 《Ann. N. Y. Acad. Sci.》 909 (1): 233–246. Bibcode:2000NYASA.909..233S. doi:10.1111/j.1749-6632.2000.tb06685.x. PMID 10911933. Methamphetamine, a central nervous system stimulant drug, is p-hydroxylated by CYP2D6 to less active p-OH-methamphetamine.
Krueger SK, Williams DE (June 2005). “Mammalian flavin-containing monooxygenases: structure/function, genetic polymorphisms and role in drug metabolism”. 《Pharmacol. Ther.》 106 (3): 357–387. doi:10.1016/j.pharmthera.2005.01.001. PMC 1828602. PMID 15922018.
Table 5: N-containing drugs and xenobiotics oxygenated by FMO
Cashman JR, Xiong YN, Xu L, Janowsky A (March 1999). “N-oxygenation of amphetamine and methamphetamine by the human flavin-containing monooxygenase (form 3): role in bioactivation and detoxication”. 《J. Pharmacol. Exp. Ther.》 288 (3): 1251–1260. PMID 10027866.
Schep LJ, Slaughter RJ, Beasley DM (August 2010). “The clinical toxicology of metamfetamine”. 《Clinical Toxicology》 48 (7): 675–694. doi:10.3109/15563650.2010.516752. ISSN 1556-3650. PMID 20849327.

pubchem.ncbi.nlm.nih.gov

〈Chemical and Physical Properties〉. 《Methamphetamine》. 《PubChem Compound》. National Center for Biotechnology Information.
〈Toxicity〉. 《Methamphetamine》. 《PubChem Compound》. National Center for Biotechnology Information.

resource.org

bulk.resource.org

United States Congress Senate Committee on the Judiciary Subcommittee to Investigate Juvenile Delinquincy (1972년 1월 1일). 《Amphetamine legislation 1971: Hearings, Ninety-second Congress, first session, pursuant to S. Res. 32, section 12, investigation of juvenile delinquency in the United States》 (PDF). U.S. Govt. Print. Off. 161쪽. 2010년 5월 6일에 원본 문서 (PDF)에서 보존된 문서. 2016년 1월 1일에 확인함. We made a decision in January of 1969 to cease the manufacture of injectable methamphetamines.

spo.go.kr

대검찰청. 《마약류 범죄백서 2020》. 32쪽.
대검찰청 (2021. 6. 9.). 《마약류 범죄백서 2020》.

web.archive.org

“보관된 사본”. 2019년 4월 1일에 원본 문서에서 보존된 문서. 2019년 4월 4일에 확인함.
“보관된 사본”. 2019년 4월 1일에 원본 문서에서 보존된 문서. 2019년 4월 4일에 확인함.
“보관된 사본”. 2019년 4월 1일에 원본 문서에서 보존된 문서. 2019년 4월 4일에 확인함.
United States Congress Senate Committee on the Judiciary Subcommittee to Investigate Juvenile Delinquincy (1972년 1월 1일). 《Amphetamine legislation 1971: Hearings, Ninety-second Congress, first session, pursuant to S. Res. 32, section 12, investigation of juvenile delinquency in the United States》 (PDF). U.S. Govt. Print. Off. 161쪽. 2010년 5월 6일에 원본 문서 (PDF)에서 보존된 문서. 2016년 1월 1일에 확인함. We made a decision in January of 1969 to cease the manufacture of injectable methamphetamines.

who.int

extranet.who.int

“Details about INN Request 1879”. 2021년 6월 12일에 확인함.

who.int

“INN Recommended List 26” (영어). 2021년 6월 11일에 확인함.

worldcat.org

Schep LJ, Slaughter RJ, Beasley DM (August 2010). “The clinical toxicology of metamfetamine”. 《Clinical Toxicology》 48 (7): 675–694. doi:10.3109/15563650.2010.516752. ISSN 1556-3650. PMID 20849327.